|
2009
|
Invention
|
Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands. The present ... |
|
2007
|
Invention
|
Heterocyclic compounds with cxcr3 antagonist activity. The present application discloses a compou... |
|
|
Invention
|
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression. The presen... |
|
|
Invention
|
8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression. The present invention ... |
|
|
Invention
|
Pyrazolopyrimidines as cyclin dependent kinase inhibitors. In its many embodiments, the present i... |
|
|
Invention
|
N-heterocyclic inhibitors of tnf-alpha expression. N-heterocyclic compounds that block cytokine p... |
|
|
Invention
|
Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity. The present applica... |
|
|
Invention
|
3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands.
Disclosed are novel... |
|
|
Invention
|
3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands. Disclosed are novel ... |
|
|
Invention
|
2-aminobenzimidazoles for treating neurodegenerative diseases. There are disclosed 2-aminobenzimi... |
|
|
Invention
|
Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity. The present applicati... |
|
|
Invention
|
Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists. ... |
|
|
Invention
|
8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders. This invention relates to 8-... |
|
|
Invention
|
Benzodiazepine gcnf modulators for stem cell modulation. A genus of benzodiazepines that modulate... |
|
2006
|
Invention
|
Compounds with medicinal effects due to interaction with the glucocorticoid receptor. The inventi... |
|
|
Invention
|
Vla-4 inhibitor compounds.
Compounds that selectively inhibit the binding of ligands to α4β1 in... |
|
|
Invention
|
Purinone derivatives for treating neurodegenerative diseases. The invention relates to purinone d... |
|
|
Invention
|
Aminopurine derivatives for treating neurodegenerative diseases. The invention relates to aminopu... |
|
|
Invention
|
Alpha2c adrenoreceptor agonists. In its many embodiments, the present invention relates to a nove... |
|
|
Invention
|
Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists. In its many embo... |
|
|
Invention
|
Substituted 2-aminothiazoles for treating neurodegenerative diseases.
The invention relates to s... |
|
|
Invention
|
Substituted 2-aminothiazoles for treating neurodegenerative diseases. The invention relates to su... |
|
|
Invention
|
2-aminoimidazopyridines for treating neurodegenerative diseases. The invention relates to 2-amino... |
|
|
Invention
|
N-heterocyclic inhibitors of tnf-α expression. N-heterocyclic compounds that block cytokine produ... |
|
|
Invention
|
Substituted ⏧1,4]-diazepanes as cxcr3 antagonists and their use in the treatment of inflamma... |
|
|
Invention
|
Heterocyclic aspartyl protease inhibitors, preparation and use thereof. Disclosed are compounds o... |
|
|
Invention
|
Aspartyl protease inhibitors. Disclosed are compounds of the formula I here or a stereoisomer, ta... |
|
|
Invention
|
Azinone and diazinone v3 inhibitors for depression and stress disorders. Substituted pyridines, p... |
|
|
Invention
|
Purine and imidazopyridine derivatives for immunosuppression. The present invention provides nove... |
|
|
Invention
|
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors.
In its many embodiments, the pr... |
|
|
Invention
|
Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity. The prese... |
|
|
Invention
|
Piperazine-piperidines with cxcr3 antagonist activity. The present application discloses a compou... |
|
|
Invention
|
Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity. The p... |
|
|
Invention
|
Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity. The present... |
|
|
Invention
|
Heterocyclic substituted piperazines with cxcr3 antagonist activity. The present application disc... |
|
|
Invention
|
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity... |
|
|
Invention
|
Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity. The present applicat... |
|
2005
|
Invention
|
Nitrogen heterocycle biaryls for osteoporosis and other diseases. Nitrogen heterocycle biaryls ha... |
|
|
Invention
|
Heterocyclic aspartyl protease inhibitors. Disclosed are compounds of the formula (I) or a stereo... |
|
|
Invention
|
Protein phosphorylation assay. The present invention provides methods for assaying the activity o... |
|
2004
|
Invention
|
Vla-4 inhibitor compounds. Compounds that selectively inhibit the binding of ligands to α4β1 inte... |
|
|
Invention
|
Pyrimidine derivatives as il-8 receptor antagonists. Compounds containing the pyrimidine nucleus ... |
|
2003
|
Invention
|
Novel gamma secretase inhibitors. This invention discloses novel gamma secretase inhibitors of th... |
|
|
Invention
|
Methods for measuring kinase activity and phosphatase activity. A method for determining the leve... |
|
|
Invention
|
Chemically inert molecular alkane or oxaalkane-tags and their identification by reaction with flu... |
|
|
Invention
|
Farnesyl protein transferase inhibitors as antitumor agents. Disclosed are novel tricyclic compou... |
|
|
Invention
|
Gamma secretase inhibitors. This invention discloses novel gamma secretase inhibitors of the form... |
|
2002
|
Invention
|
Pyrimidine and triazine kinase inhibitors.
As selective inhibitors of inappropriate kinase activ... |
|
1999
|
Invention
|
Combinatorial dihydrobenzopyran library. Combinatorial libraries are disclosed which are represen... |
